Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

Rebbeck, Timothy R. and Friebel, Tara M. and Friedman, Eitan and Hamann, Ute and Huo, Dezheng and Kwong, Ava and Olah, Edith and Olopade, Olufunmilayo I. and Solano, Angela R. and Teo, Soo-Hwang and Thomassen, Mads and Weitzel, Jeffrey N. and Chan, T. L. and Couch, Fergus J. and Goldgar, David E. and Kruse, Torben A. and Palmero, Edenir Inez and Park, Sue Kyung and Torres, Diana and van Rensburg, Elizabeth J. and McGuffog, Lesley and Parsons, Michael T. and Leslie, Goska and Aalfs, Cora M. and Abugattas, Julio and Adlard, Julian and Agata, Simona and Aittomaki, Kristiina and Andrews, Lesley and Andrulis, Irene L. and Arason, Adalgeir and Arnold, Norbert and Arun, Banu K. and Asseryanis, Ella and Auerbach, Leo and Azzollini, Jacopo and Balmana, Judith and Barile, Monica and Barkardottir, Rosa B. and Barrowdale, Daniel and Benitez, Javier and Berger, Andreas and Berger, Raanan and Blanco, Amie M. and Blazer, Kathleen R. and Blok, Marinus J. and Bonadona, Valerie and Bonanni, Bernardo and Bradbury, Angela R. and Brewer, Carole and Buecher, Bruno and Buys, Saundra S. and Caldes, Trinidad and Caliebe, Almuth and Caligo, Maria A. and Campbell, Ian and Caputo, Sandrine M. and Chiquette, Jocelyne and Chung, Wendy K. and Claes, Kathleen B. M. and Collee, J. Margriet and Cook, Jackie and Davidson, Rosemarie and de la Hoya, Miguel and De Leeneer, Kim and de Pauw, Antoine and Delnatte, Capucine and Diez, Orland and Ding, Yuan Chun and Ditsch, Nina and Domchek, SusanM. and Dorfling, Cecilia M. and Velazquez, Carolina and Dworniczak, Bernd and Eason, Jacqueline and Easton, Douglas F. and Eeles, Ros and Ehrencrona, Hans and Ejlertsen, Bent and Engel, Christoph and Engert, Stefanie and Evans, D. Gareth and Faivre, Laurence and Feliubadalo, Lidia and Ferrer, Sandra Fert and Foretova, Lenka and Fowler, Jeffrey and Frost, Debra and Galvao, Henrique C. R. and Ganz, Patricia A. and Garber, Judy and Gauthier-Villars, Marion and Gehrig, Andrea and Gerdes, Anne-Marie and Gesta, Paul and Giannini, Giuseppe and Giraud, Sophie and Glendon, Gord and Godwin, Andrew K. and Greene, Mark H. and Gronwald, Jacek and Gutierrez-Barrera, Angelica and Hahnen, Eric and Hauke, Jan and Henderson, Alex and Hentschel, Julia and Hogervorst, Frans B. L. and Honisch, Ellen and Imyanitov, Evgeny N. and Isaacs, Claudine and Izatt, Louise and Izquierdo, Angel and Jakubowska, Anna and James, Paul and Janavicius, Ramunas and Jensen, Uffe Birk and John, Esther M. and Vijai, Joseph and Kaczmarek, Katarzyna and Karlan, Beth Y. and Kast, Karin and Kim, Sung-Won and Konstantopoulou, Irene and Korach, Jacob and Laitman, Yael and Lasa, Adriana and Lasset, Christine and Lazaro, Conxi and Lee, Annette and Lee, Min Hyuk and Lester, Jenny and Lesueur, Fabienne and Liljegren, Annelie and Lindor, Noralane M. and Longy, Michel and Loud, Jennifer T. and Lu, Karen H. and Lubinski, Jan and Machackova, Eva and Manoukian, Siranoush and Mari, Veronique and Martinez-Bouzas, Cristina and Matrai, Zoltan and Mebirouk, Noura and Meijers-Heijboer, Hanne E. J. and Meindl, Alfons and Mensenkamp, Arjen R. and Mickys, Ugnius and Miller, Austin and Montagna, Marco and Moysich, Kirsten B. and Mulligan, Anna Marie and Musinsky, Jacob and Neuhausen, Susan L. and Nevanlinna, Heli and Ngeow, Joanne and Nguyen, Huu Phuc and Niederacher, Dieter and Nielsen, Henriette Roed and Nielsen, Finn Cilius and Nussbaum, Robert L. and Offit, Kenneth and Ofverholm, Anna and Ong, Kai-ren and Osorio, Ana and Papi, Laura and Papp, Janos and Pasini, Barbara and Pedersen, Inge Sokilde and Peixoto, Ana and Peruga, Nina and Peterlongo, Paolo and Pohl, Esther and Pradhan, Nisha and Prajzendanc, Karolina and Prieur, Fabienne and Pujol, Pascal and Radice, Paolo and Ramus, Susan J. and Rantala, Johanna and Rashid, Muhammad Usman and Rhiem, Kerstin and Robson, Mark and Rodriguez, Gustavo C. and Rogers, Mark T. and Rudaitis, Vilius and Schmidt, Ane Y. and Schmutzler, Rita Katharina and Senter, Leigha and Shah, Payal D. and Sharma, Priyanka and Side, Lucy E. and Simard, Jacques and Singer, Christian F. and Skytte, Anne-Bine and Slavin, Thomas P. and Snape, Katie and Sobol, Hagay and Southey, Melissa and Steele, Linda and Steinemann, Doris and Sukiennicki, Grzegorz and Sutter, Christian and Szabo, Csilla I. and Tan, Yen Y. and Teixeira, Manuel R. and Terry, Mary Beth and Teule, Alex and Thomas, Abigail and Thull, Darcy L. and Tischkowitz, Marc and Tognazzo, Silvia and Toland, Amanda Ewart and Topka, Sabine and Trainer, Alison H. and Tung, Nadine and van Asperen, Christi J. and van der Hout, Annemieke H. and van der Kolk, Lizet E. and van der Luijt, Rob B. and Van Heetvelde, Mattias and Varesco, Liliana and Varon-Mateeva, Raymonda and Vega, Ana and Villarreal-Garza, Cynthia and von Wachenfeldt, Anna and Walker, Lisa and Wang-Gohrke, Shan and Wappenschmidt, Barbara and Weber, Bernhard H. F. and Yannoukakos, Drakoulis and Yoon, Sook-Yee and Zanzottera, Cristina and Zidan, Jamal and Zorn, Kristin K. and Selkirk, Christina G. Hutten and Hulick, Peter J. and Chenevix-Trench, Georgia and Spurdle, Amanda B. and Antoniou, Antonis C. and Nathanson, Katherine L. (2018) Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. HUMAN MUTATION, 39 (5). pp. 593-620. ISSN 1059-7794, 1098-1004

Full text not available from this repository. (Request a copy)

Abstract

The prevalence and spectrum of germline mutations in BRCA1 and BRCA2 have been reported in single populations, with the majority of reports focused on White in Europe and North America. The Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) has assembled data on 18,435 families with BRCA1 mutations and 11,351 families with BRCA2 mutations ascertained from 69 centers in 49 countries on six continents. This study comprehensively describes the characteristics of the 1,650 unique BRCA1 and 1,731 unique BRCA2 deleterious (disease-associated) mutations identified in the CIMBA database. We observed substantial variation in mutation type and frequency by geographical region and race/ethnicity. In addition to known founder mutations, mutations of relatively high frequency were identified in specific racial/ethnic or geographic groups that may reflect founder mutations and which could be used in targeted (panel) first pass genotyping for specific populations. Knowledge of the population-specific mutational spectrum in BRCA1 and BRCA2 could inform efficient strategies for genetic testing and may justify a more broad-based oncogenetic testing in some populations.

Item Type: Article
Uncontrolled Keywords: BREAST-CANCER PATIENTS; GERMLINE MUTATIONS; FOUNDER MUTATIONS; HIGH-RISK; HAPLOTYPE ANALYSIS; HEREDITARY BREAST; PHENOTYPE ANALYSIS; 185DELAG MUTATION; RECURRENT BRCA1; GENE-MUTATIONS; BRCA1; BRCA2; breast cancer; ethnicity; geography; mutation; ovarian cancer
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Humangenetik
Depositing User: Dr. Gernot Deinzer
Date Deposited: 09 Mar 2020 14:10
Last Modified: 09 Mar 2020 14:10
URI: https://pred.uni-regensburg.de/id/eprint/14609

Actions (login required)

View Item View Item